NFL Alum Group, Neuralstem Set Trial With Brain Injury Drug
The National Football League Alumni Association (NFLAA) and Neuralstem Inc. are working together to develop a trial using one of the company’s drugs to treat retired football players suffering from traumatic brain injuries (TBI). In a press release Wednesday, the two announced that the trial would incorporate NSI-189, the lead..
Read more